TORONTO, July 31, 2018 /PRNewswire-PRWeb/ -- Zymewire, a SaaS company developing machine learning-based solutions for
After being selected for the program from over 600 applicant companies in September 2017, Zymewire is among 60 ventures in the latest cohort to graduate. "There is no question we emerged as a different company than when we started 8 months prior. Through the CDL network and the advice we received throughout the program, we now have a clear path to our next major revenue inflection point and clarity around what our company will look like as we add the next 85 team members" said Pete Bastedo, Zymewire's CEO & Co-Founder. "The depth of expertise and raw intelligence in the room at CDL is just humbling: everyone from leading academic luminaries of AI through to entrepreneurs who have built billion dollar companies from the ground up. CDL gave us the chance to to sit down with dozens of incredible thought leaders and get insight and advice into how to move Zymewire forward in every way." said Ryan Drake-Stoker, Zymewire's CTO & Co-Founder.
After completing CDL, Zymewire now has their sights set on adding members to their team and expanding upon the success that they have achieved. "We have big plans in the future across many more industries and verticals where we see applications of our machine learning-based technologies!"
About Zymewire Zymewire provides the machine learning-enabled digital sales research assistant, helping sales professionals identify new opportunities for growth by combining deep market intelligence with existing internal data, all without having to rely on analyst-populated databases. Supporting business development teams at more than 230 pharmaceutical and biotech service providers worldwide, Zymewire has become the trusted resource for sales research and prospecting. For more information, please visit: http://www.zymewire.com
About the Creative Destruction Lab The Creative Destruction Lab (CDL) is a seed-stage program for massively scalable, science-based companies. The nine-month program employs an objectives-based mentoring process with the goal of maximizing equity-value creation. The CDL is particularly suited to early stage companies with links to university research labs. Launched in 2012 at the Rotman School of Management at the University of Toronto, the program has now expanded with locations in Vancouver, Calgary, Montreal, Halifax, and New York City. Companies that graduated from the Lab's first five cohorts between 2012 and 2017 have generated more than $2.5 billion (CAD) in aggregate equity value. CDL graduates include Atomwise (San Francisco), Deep Genomics (Toronto), Thalmic Labs (Waterloo), Nymi (Toronto), Automat (Montreal), BenchSci (Toronto), Kyndi (Palo Alto), Kepler (Toronto), and Heuritech (Paris).
All media inquiries may be sent to:
Sean Cannon, Marketing Manager email@example.com
Subscribe to our Free Newsletters!
Mastocytosis is a rare condition marked by accumulation of mast cells under the skin and various ...
Lusutrombopag is used to treat abnormally low platelet counts (thrombocytopenia) in adult patients ...
Stereotypic movement disorder (SMD) is a motor disorder, associated with neurodevelopmental ...View All